This site is intended for health professionals only

Published on 1 August 2007

Share this story:

RELATED ARTICLES
Join us for new Clinical Excellence in Respiratory Care event
Dismayed reactions from sector over proposed GPhC fees increase
Dapagliflozin use in heart failure extended by NICE to reduce hospitalisations
Study confirms spironolactone safe and effective for treating acne in women
Calls for HCPs to respond to major conditions strategy consultation

Step forward for Tamiflu

teaser

Roche has received a positive opinion in Europe from the Committee of Human Medicinal Products (CHMP) recommending marketing authorisation for Tamiflu



Most read

1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
2
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
3
Oral vitamin A could become an alternative to isotretinoin for acne
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
5
Pharmacy workforce: matching staffing resource to service demand 



Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:

RELATED ARTICLES
Omega-3 supplements reduce stress-related inflammatory markers
Vuity (pilocarpine) approved by FDA for presbyopia
A new specialisation curriculum for hospital pharmacists in Finland
Managing risks: no time for complacency
Immune-mediated inflammatory diseases do not increase the risk of COVID-19 infection

Download Hospital Pharmacy Europe free app

Download our app from the Apple App Store Download our app from Google Play

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
×